MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt
· Delayed Price · Currency is EGP 351.23
+9.38 (2.74%)
At close: Dec 3, 2025
MINAPHARM Pharmaceuticals Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,040 | 1,796 | 2,408 | 1,822 | 1,303 | 987 | Upgrade
|
| Market Cap Growth | 111.05% | -25.41% | 32.19% | 39.82% | 32.02% | -5.49% | Upgrade
|
| Enterprise Value | 5,738 | 4,355 | 4,087 | 2,625 | 1,448 | 1,101 | Upgrade
|
| Last Close Price | 342.94 | 160.66 | 213.62 | 143.60 | 100.70 | 74.31 | Upgrade
|
| PE Ratio | 32.46 | 14.02 | - | 3.09 | 2.91 | 3.46 | Upgrade
|
| PS Ratio | 0.58 | 0.32 | 0.62 | 0.50 | 0.43 | 0.42 | Upgrade
|
| PB Ratio | 0.68 | 0.41 | 0.69 | 0.60 | 0.67 | 0.62 | Upgrade
|
| P/TBV Ratio | 0.77 | 0.48 | 0.80 | 0.70 | 0.81 | 0.79 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 3.44 | Upgrade
|
| P/OCF Ratio | 10.73 | 8.11 | 23.53 | 3.24 | 6.29 | 2.26 | Upgrade
|
| EV/Sales Ratio | 0.83 | 0.77 | 1.05 | 0.73 | 0.48 | 0.47 | Upgrade
|
| EV/EBITDA Ratio | 3.31 | 3.72 | 7.63 | 2.42 | 1.73 | 1.77 | Upgrade
|
| EV/EBIT Ratio | 4.15 | 4.66 | 10.91 | 2.72 | 1.92 | 2.04 | Upgrade
|
| EV/FCF Ratio | -13.15 | - | - | - | - | 3.84 | Upgrade
|
| Debt / Equity Ratio | 0.91 | 1.24 | 1.07 | 0.80 | 0.64 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 3.13 | 4.48 | 6.67 | 2.22 | 1.49 | 1.54 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 3.34 | Upgrade
|
| Asset Turnover | 0.55 | 0.55 | 0.50 | 0.66 | 0.79 | 0.74 | Upgrade
|
| Inventory Turnover | 3.31 | 3.26 | 2.79 | 2.82 | 2.90 | 2.73 | Upgrade
|
| Quick Ratio | 1.06 | 0.79 | 0.70 | 0.87 | 0.92 | 0.84 | Upgrade
|
| Current Ratio | 1.49 | 1.25 | 1.15 | 1.46 | 1.61 | 1.34 | Upgrade
|
| Return on Equity (ROE) | 3.22% | 4.06% | 0.68% | 25.32% | 26.86% | 21.14% | Upgrade
|
| Return on Assets (ROA) | 6.85% | 5.64% | 3.02% | 11.05% | 12.42% | 10.56% | Upgrade
|
| Return on Capital (ROIC) | 8.06% | 6.80% | 3.67% | 13.92% | 16.41% | 14.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.50% | 12.60% | 7.20% | 22.40% | 28.80% | 29.10% | Upgrade
|
| Earnings Yield | 3.87% | 8.74% | -1.33% | 33.63% | 35.79% | 30.47% | Upgrade
|
| FCF Yield | -10.80% | -38.82% | -53.66% | -32.84% | -13.86% | 29.06% | Upgrade
|
| Dividend Yield | 0.73% | 1.56% | 0.77% | 1.95% | 2.90% | 3.63% | Upgrade
|
| Payout Ratio | 29.01% | 25.57% | - | 9.43% | 10.68% | 29.33% | Upgrade
|
| Buyback Yield / Dilution | -33.72% | - | 3.57% | 6.67% | - | - | Upgrade
|
| Total Shareholder Return | -32.99% | 1.56% | 4.34% | 8.62% | 2.90% | 3.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.